Clinical Trial Update: VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation

View source ↗

Summary

A completed study evaluating VedAryo (vedolizumab) for effectiveness and safety in ulcerative colitis and Crohn's disease. The update reports the trial outcomes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• VedAryo (Vedolizumab)

Snippet

Sponsor: AryoGen Pharmed Co. | Conditions: Ulcerative Colitis (UC), Crohn Disease (CD) | Status: COMPLETED